Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Data-Only Studies
Biospecimen Studies

Results: 1030 (Showing 21 to 40) — Export these results

Name Principal Investigator Institution Study Date Approved Project ID
The "MetaboMap" project Steven Moore NCI PLCO Apr 23, 2020 PLCO-615
The association of dietary fats and carbohydrates with total and cause-specific mortality in PLCO cohort Xin Xu The First Affiliated Hospital, School of Medicine, Zhejiang University PLCO Apr 23, 2020 PLCO-587
Prostate-specific antigen screening rates and factors associated with screening in American men Ming Liu Beijing Hospital PLCO Apr 16, 2020 PLCO-606
Development of a Novel Prognostic Model for Predicting Metastasis using CNN method in Colorectal Cancer Min Seob Kwak Kyung Hee university at Gangdong PLCO Apr 16, 2020 PLCOI-607
ProstAId-CDS - A Clinical Decision Support System for Prostate Cancer Treatment Stefan Bonn University Medical Center Hamburg Eppendorf / ZMNH PLCO Mar 27, 2020 PLCOI-589
Estimating the probability of overdiagnosis in PLCO trial Jian-Lun Xu NCI PLCO Mar 25, 2020 PLCO-600
A systematic assessment of different environmental, lifestyle, medical and familial factors associated with risk of liver cancer and survival Youzhu Wei Fujian Medical University PLCO Mar 25, 2020 PLCO-604
Master Degree on Prostate Cancer Survival Katarzyna Adamska Warsaw School of Economics PLCO Mar 20, 2020 PLCO-596
Biomarkers of Exposure and Response to Coffee Intake Erikka Loftfield National Cancer Institute PLCO Mar 20, 2020 PLCO-599
Early Diagnosis of Asthma, Thyroid Cancer and Schizophrenia Diseases Using Computational Intelligence Techniques Sarah Alotaibi IAU PLCO Mar 20, 2020 PLCO-603
EEMS Methods Study Work Zvi Livneh Weizmann Institute in Isreal PLCO Mar 18, 2020 2020-9001
Aspirin use and risk of hepatocellular carcinoma incidence and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Holli Loomans-Kropp National Cancer Institute PLCO Mar 18, 2020 PLCO-601
Dietary inflammatory potential and risk of liver cancer in the PLCO study Xuehong Zhang The Brigham and Women’s Hospital, Inc. PLCO Mar 16, 2020 PLCO-598
A Machine Learning Approach to Bladder Cancer Screening and Cancer Grade/Stage Differentiation Herbert Chase The Trustees of Columbia University in the City of New York PLCO Mar 16, 2020 PLCO-597
Association of colorectal polyps with dietary inflammation during screening colonoscopy in Men and Women Bhaumik Brahmbhatt Mayo Clinic PLCO Mar 16, 2020 PLCO-593
Risk Prediction Model for Endometrial Cancer using multiple Machine Learning Algorithms and Meta-Analysis Denis Mihaies Brunel Univeristy PLCO Mar 16, 2020 PLCO-590
Interpretable Artificial Intelligence to select patients that will benefit from lung cancer screening Jean-Emmanuel Bibault Stanford University PLCO Mar 5, 2020 PLCO-594
Personalizing colorectal treatment strategies through machine learning Jean-Emmanuel Bibault Stanford University PLCO Feb 27, 2020 PLCO-592
Treatment effect on the Survival Time of Lung Cancer Patients Jing Zhou Department of Family and Preventive Medicine PLCO Feb 27, 2020 PLCO-591
A Machine Learning Approach to Diagnosing Breast Cancer Michele La Ferla University of Malta PLCO Feb 19, 2020 PLCOI-585